About
Platform
Therapeutics
Partnering
Careers
Newsroom
Publications
Contact
X
LinkedIn
info@bighatbio.com
About
About
Platform
Platform
Therapeutics
Therapeutics
Partnering
Partnering
Careers
Careers
Newsroom
Newsroom
Publications
Publications
X
X
LinkedIn
LinkedIn
Contact Us
The Latest
Newsroom
All
Announcements
Press
Publications
Presentations
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
9/24/2026
BigHat Biosciences Announces $75 Million Series C Financing to Advance AI-Designed Therapeutics and Leading Agentic Data Platform for Rapid Protein Design
Announcements
9/1/2026
BigHat Biosciences Announces First Patient Dosed in Phase 1 Trial Evaluating BHB810, a Novel CDH17-Directed Antibody-Drug Conjugate, for the Treatment of Gastric Cancer and other Advanced Gastrointestinal Tumors
Press
Recent Posts
12/14/2020
Antibody developer Steve Doberstein joins BigHat advisory team
Announcements
11/18/2020
Peyton Greenside, BigHat CSO, speaks about machine-guided biological design
Announcements
11/1/2020
BigHat Biosciences earns Phase I award from NIST to show power of AI-driven platform
Announcements
9/15/2020
BigHat awarded 2020 Golden Ticket from Amgen and MBC Biolabs
Announcements
8/12/2020
BigHat founder discusses COVID-19's impact on early-stage startups
Announcements
7/18/2020
BigHat founder presents active learning innovations at ICML 2020
Announcements
6/9/2020
BigHat founder speaks at the annual European Society for Human Genetics (ESHG) 2020 meeting
Announcements
4/30/2020
BigHat founder talks leading interdisciplinary teams with Stanford Accel Scholars
Announcements
12/4/2019
BigHat founder at the Cell Free Systems conference
Announcements
11/11/2019
BigHat founder moderates Deep Life salon
Announcements
10/30/2019
BigHat founder speaks at Open Data Science conference
Announcements
10/22/2019
BigHat closes oversubscribed seed round
Announcements
Previous
5 / 5
© BigHat Bio 2026